The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease.

Mario TranfaMario TortoraGiuseppe PontilloValentina IuzzolinoEleonora RiccioSimona CaccavalloTeodolinda Di RisiSerena MontiRoberta LanzilloVincenzo Brescia MorraGiuseppe PalmaMaria PetraccaAntonio PisaniArturo BrunettiSirio Cocozza

Published in: European radiology (2022)

• The search for new imaging biomarkers is crucial to achieve a correct neuroradiological diagnosis of MS. • The CVS shows an incidence superior to 70% in MS patients, even in the early phases of the disease, while it appears to be absent in FD. • These findings further corroborate the possible future central role of CVS in distinguishing between MS and its mimickers.

Keyphrases

multiple sclerosis
mass spectrometry
ms ms
end stage renal disease
ejection fraction
high resolution
risk factors
white matter
peritoneal dialysis
prognostic factors
computed tomography
replacement therapy
current status
patient reported outcomes
contrast enhanced